PWS Subtypes May Respond Differently to Psychotropic Treatments

PWS Subtypes May Respond Differently to Psychotropic Treatments

287596

PWS Subtypes May Respond Differently to Psychotropic Treatments

A small study exploring gene alterations related to Prader-Willi syndrome (PWS) suggests that subtypes of the disorder have different genetic profiles that may affect response to psychotropic treatments and potential side effects. Due to its small size, only trends rather than statistically significant differences were observed. Still, obsessive behaviors and mood disorders mark some PWS subtypes, and study findings indicate that “gene testing should be considered before initiating pharmacotherapy in PWS,” the scientists wrote. The study, “Pharmacodynamic…

You must be logged in to read/download the full post.